Cochrane Abstracts
Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Calcineurin Inhibitor Minimisation Versus Continuation of Calcineurin Inhibitor Treatment for Liver Transplant Recipients." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434412/all/Calcineurin_inhibitor_minimisation_versus_continuation_of_calcineurin_inhibitor_treatment_for_liver_transplant_recipients.
Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434412/all/Calcineurin_inhibitor_minimisation_versus_continuation_of_calcineurin_inhibitor_treatment_for_liver_transplant_recipients. Accessed January 16, 2026.
Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434412/all/Calcineurin_inhibitor_minimisation_versus_continuation_of_calcineurin_inhibitor_treatment_for_liver_transplant_recipients
Calcineurin Inhibitor Minimisation Versus Continuation of Calcineurin Inhibitor Treatment for Liver Transplant Recipients [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434412/all/Calcineurin_inhibitor_minimisation_versus_continuation_of_calcineurin_inhibitor_treatment_for_liver_transplant_recipients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients
ID - 434412
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434412/all/Calcineurin_inhibitor_minimisation_versus_continuation_of_calcineurin_inhibitor_treatment_for_liver_transplant_recipients
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
